Medicare Enrolled

Dr. Alexis Katz, D.O.

Rheumatology · Boca Raton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1050 NW 15TH ST STE 212A, Boca Raton, FL 33486
5613685611
In practice since 2015 (10 years)
NPI: 1194102756 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Katz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Katz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Katz

Dr. Alexis Katz is a rheumatology in Boca Raton, FL, with 10 years in practice. Based on federal Medicare data, Dr. Katz performed 44,593 Medicare services across 4,521 unique beneficiaries.

Between the years covered by Open Payments, Dr. Katz received a total of $5,430 from 29 pharmaceutical and/or device companies across 265 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Katz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice▲ Top 38% volume in FL$ $5,430 industry payments

Medicare Practice Summary

Medicare Utilization ↗
44,593
Medicare services
Top 38% in FL for rheumatology
4,521
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,459 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)22,200$19$25
Romosozumab injection (Evenity) for osteoporosis15,120$8$15
Abatacept infusion (Orencia)1,775$34$60
Blood draw (venipuncture)584$8$10
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle543$59$134
Office visit, established patient (30-39 min)485$101$271
Calcium level, total324$5$12
Vitamin D level test320$29$73
Blood creatinine level247$5$11
Urea nitrogen level to assess kidney function, quantitative241$4$10
Red blood cell sedimentation rate, to detect inflammation, non-automated240$4$9
C-reactive protein test (inflammation marker)235$5$13
Office visit, established patient (20-29 min)215$72$191
New patient office visit (45-59 min)187$134$354
Complete blood count (CBC) with differential163$8$19
Liver function blood test panel149$8$20
Blood potassium level144$5$10
Blood sodium level141$5$10
Blood glucose (sugar) level140$4$10
Measurement of antibody for assessment of autoimmune disorder, any method110$18$89
Parathyroid hormone level test69$40$102
Analysis of substance using immunoassay technique, multiple step method66$11$28
Office visit, established patient, complex (40-54 min)65$144$379
Rheumatoid factor analysis62$6$14
Measurement of complement (immune system proteins), antigen,60$12$59
Bone density scan (DEXA)55$39$79
Injection, zoledronic acid, 1 mg55$6$45
Screening test for antibody to noninfectious agent48$12$29
Administration of chemotherapy into vein, 1 hour or less45$103$205
Thyroid stimulating hormone (TSH) test43$16$42
Injection into tendon or ligament40$40$120
New patient office visit (30-44 min)40$90$237
Creatine kinase (cardiac enzyme) level, total39$6$16
Joint injection, major joint38$57$150
Free thyroxine (T4) test36$9$22
Phosphate level test35$5$10
Injection, methylprednisolone acetate, 40 mg34$6$12
Screening test for autoimmune disorder33$12$30
Phosphatase (enzyme) measurement, alkaline, isoenzymes31$14$30
Measurement of dna antibody, native or double stranded29$13$34
Steroid injection (triamcinolone)29$1$10
New patient office visit, complex (60-74 min)28$182$468
Uric acid level test24$4$11
Injection, methylprednisolone acetate, 80 mg15$9$22
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less11$52$105
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.0% high complexity
85.5% medium
10.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,430
Total received (2018-2024)
Avg $905/year across 6 years
Bottom 44% in FL for rheumatology
29
Companies
265
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,345 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,317
2023
$1,474
2022
$1,202
2021
$901
2019
$14
2018
$524

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$950
Janssen Biotech, Inc.
$576
Amgen Inc.
$553
Novartis Pharmaceuticals Corporation
$514
Genentech USA, Inc.
$430
UCB, Inc.
$419
E.R. Squibb & Sons, L.L.C.
$332
GlaxoSmithKline, LLC.
$266
Radius Health, Inc.
$175
Alvogen Inc
$162
AbbVie Inc.
$138
Boehringer Ingelheim Pharmaceuticals, Inc.
$117
PFIZER INC.
$115
AbbVie, Inc.
$94
AstraZeneca Pharmaceuticals LP
$83
Mallinckrodt Hospital Products Inc.
$76
Lilly USA, LLC
$69
Fresenius Kabi USA, LLC
$61
Actelion Pharmaceuticals US, Inc.
$55
Horizon Therapeutics plc
$41
ANI Pharmaceuticals, Inc.
$34
Aurinia Pharma U.S., Inc.
$32
Alexion Pharmaceuticals, Inc.
$29
SOBI, INC
$22
Kiniksa Pharmaceuticals International, plc
$20
SCILEX PHARMACEUTICALS INC.
$19
Organon LLC
$19
Cumberland Pharmaceuticals, Inc.
$16
Mallinckrodt Enterprises LLC
$14
Top 3 companies account for 38.3% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · HUMIRA · Humira · IDACIO · KINERET · KRYSTEXXA · LUPKYNIS · NA · OFEV · OPSUMIT · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · Prolia · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $12 per 100 Medicare services performed
Looking for a rheumatology in Boca Raton?
Compare rheumatologys in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
67
Per 100K population
4.4
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Katz is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Katz experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Katz performed 22,200 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Katz receive payments from pharmaceutical companies?
Yes. Dr. Katz received a total of $5,430 from 29 companies across 265 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Katz's costs compare to other rheumatologys in Boca Raton?
Dr. Katz's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Katz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →